fudosteine has been researched along with cystine in 13 studies
| Studies (fudosteine) | Trials (fudosteine) | Recent Studies (post-2010) (fudosteine) | Studies (cystine) | Trials (cystine) | Recent Studies (post-2010) (cystine) |
|---|---|---|---|---|---|
| 24 | 3 | 12 | 6,431 | 97 | 1,084 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Isohama, Y; Kai, H; Miyata, T; Mizuno, H; Nagaoka, S; Ohno, H; Takahama, K; Takahashi, K | 1 |
| Ishikawa, M; Iwase, N; Kai, H; Koda, T; Miyata, T; Mizuno, H; Takahashi, K | 1 |
| Kai, H; Koda, T; Miyata, T; Mizuno, H; Takahashi, K | 1 |
| Goto, K; Komatsu, H; Komorita, N; Ochi, H; Okumoto, T; Takagi, S; Yamaguchi, S | 1 |
| Ding, L; Li, RS; Shen, JP; Yang, J; Zhang, YD; Zhou, M | 1 |
| Chen, Y; Jiao, H; Tian, Y; Xu, F; Zhang, B; Zhang, Z | 1 |
| Fan, G; Li, Z; Qi, Y; Wen, J; Wu, Y; Zhang, L | 1 |
| Kang, CM; Kim, KH; Kim, YK; Moon, HS; Park, SH; Rhee, CK; Song, JS; Yoon, HK; You, MB | 1 |
| Guo, H; Pan, Y; Qi, F; Sheng, L; Yin, H; Zhang, T | 1 |
| Barnes, PJ; Brindicci, C; Hanazawa, T; Ito, K; Ito, M; Kharitonov, S; Osoata, GO | 1 |
| Iio, K; Kanehiro, A; Kataoka, M; Shibakura, M; Tanimoto, M; Tanimoto, Y; Ueno-Iio, T | 1 |
| Gooty, AR; Hunnur, RK; Katreddi, HR; Masani, NK; S, RR; Sharma, HK | 1 |
| Chen, J; Chen, K; He, G; Hu, J; Li, W; Li, X; Liu, L; Wang, H; Wang, T; Wen, F; Xu, D; Yang, D | 1 |
2 trial(s) available for fudosteine and cystine
| Article | Year |
|---|---|
[Pharmacokinetics of fudosteine in healthy volunteers].
Topics: Administration, Oral; Adult; Area Under Curve; Body Weight; Chromatography, High Pressure Liquid; Cystine; Dose-Response Relationship, Drug; Female; Humans; Male; Sex Factors | 2005 |
Quantification of fudosteine in human plasma by high-performance liquid chromatography-electrospray ionization mass spectrometry employing precolumn derivatization with 9-fluorenylmethyl chloroformate.
Topics: Administration, Oral; Borates; Buffers; Calibration; Chromatography, High Pressure Liquid; Cystine; Female; Fluorenes; Humans; Male; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization | 2006 |
11 other study(ies) available for fudosteine and cystine
| Article | Year |
|---|---|
Effects of SS320A, a new cysteine derivative, on the change in the number of goblet cells induced by isoproterenol in rat tracheal epithelium.
Topics: Animals; Cystine; Epithelial Cells; Female; Isoproterenol; Male; Rats; Rats, Wistar; Trachea | 1998 |
[Effects of fudosteine, a new cysteine derivative, on airway secretion in rabbits and rats].
Topics: Animals; Bronchoalveolar Lavage Fluid; Cells, Cultured; Chlorine; Cystine; Epithelial Cells; Expectorants; Male; Phosphatidylcholines; Pulmonary Alveoli; Pulmonary Surfactants; Rabbits; Rats; Rats, Wistar; Respiratory System | 2000 |
Effect of fudosteine, a new cysteine derivative, on mucociliary transport.
Topics: Administration, Oral; Administration, Topical; Animals; Coturnix; Cysteine; Cystine; Female; Intestinal Mucosa; Male; Mucociliary Clearance; Tobacco Smoke Pollution; Trachea | 2001 |
Inhibition of endotoxin- and antigen-induced airway inflammation by fudosteine, a mucoactive agent.
Topics: Animals; Chemokine CXCL1; Chemokines, CXC; Cystine; Expectorants; Goblet Cells; Intercellular Signaling Peptides and Proteins; Leukotriene B4; Male; Mice; Mice, Inbred BALB C; Models, Animal; Neutrophils; Pulmonary Eosinophilia; Rats; Rats, Inbred F344; Respiratory Mucosa; Trachea | 2005 |
High-throughput determination of fudosteine in human plasma by liquid chromatography-tandem mass spectrometry, following protein precipitation in the 96-well plate format.
Topics: Chemical Precipitation; Chromatography, High Pressure Liquid; Cystine; Humans; Quality Control; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2008 |
Effect of fudosteine on mucin production.
Topics: Animals; Cell Line, Tumor; Cystine; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Lipopolysaccharides; Male; Models, Biological; Mucin 5AC; Mucins; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 2008 |
The characterization of selected drugs with infrared laser desorption/tunable synchrotron vacuum ultraviolet photoionization mass spectrometry.
Topics: Antihypertensive Agents; Captopril; Cystine; Infrared Rays; Pharmaceutical Preparations; Photochemistry; Protease Inhibitors; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Synchrotrons; Thiorphan; Ultraviolet Rays; Vacuum | 2008 |
Peroxynitrite elevation in exhaled breath condensate of COPD and its inhibition by fudosteine.
Topics: Adult; Aged; Breath Tests; Case-Control Studies; Cystine; Enzyme-Linked Immunosorbent Assay; Female; Half-Life; Humans; Inflammation Mediators; Interleukin-8; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Peroxynitrous Acid; Pilot Projects; Probability; Pulmonary Disease, Chronic Obstructive; Reference Values; Respiratory Function Tests; Sensitivity and Specificity; Severity of Illness Index; Sputum | 2009 |
Effect of fudosteine, a cysteine derivative, on airway hyperresponsiveness, inflammation, and remodeling in a murine model of asthma.
Topics: Allergens; Animals; Bronchial Hyperreactivity; Bronchoalveolar Lavage Fluid; Cystine; Female; Lung; Mice; Mice, Inbred BALB C; Real-Time Polymerase Chain Reaction; RNA, Messenger; Transforming Growth Factor beta | 2013 |
Simultaneous Determination of Genotoxic Impurities in Fudosteine Drugs by GC-MS.
Topics: Chemistry Techniques, Analytical; Cystine; Drug Contamination; Gas Chromatography-Mass Spectrometry; Limit of Detection; Mutagens; Propanols; Reproducibility of Results | 2016 |
Fudosteine attenuates acute lung injury in septic mice by inhibiting pyroptosis via the TXNIP/NLRP3/GSDMD pathway.
Topics: Acute Lung Injury; Animals; Carrier Proteins; Cystine; Inflammasomes; Lung; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Phosphate-Binding Proteins; Pore Forming Cytotoxic Proteins; Pyroptosis; Respiratory Distress Syndrome; Sepsis; Thioredoxins | 2022 |